The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice
- PMID: 19615872
- DOI: 10.1016/j.etp.2009.06.009
The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice
Abstract
The pathogenesis of limb-girdle muscular dystrophy type 2B (LGMD2B) dysferlinopathy remains to be investigated. The distribution and characterization of skeletal muscle lesions were examined in two different LGMD2B mouse models, SJL and A/J mice (at 10 and 35 weeks old), in association with the endoplasmic reticulum (ER) stress. SJL mice showed an earlier age of onset and a faster progression of skeletal muscle lesions as compared with those of A/J mice; the sensitivity difference to muscular dystrophic lesions between SJL and A/J mice was observed in the lumbar muscles (particularly, lumbar longissimus and sublumbar muscles); the lesions seen mainly in SJL mice at 35 weeks old consisted of degeneration, necrosis, fatty infiltration, variation in muscle fiber size and atrophy in muscle fibers. Enzyme-histochemically, the fast-twitch muscle fiber was predominant for the degenerative changes seen in the rectus femoris and lateral longissimus muscles of SJL mice. Immunohistochemically, the main reactive cell type observed in and around degenerative and/or necrotic muscle fibers was macrophages, demonstrable with an anti-F4/80 antibody. Because the analyses of spliced XBP1 mRNA, a marker of ER stress, did not show the increased expression, it was considered that ER stress did not affect the progression of skeletal muscle lesions in SJL mice with the advanced stage of dysferlinopathy.
(c) 2009 Elsevier GmbH. All rights reserved.
Similar articles
-
Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).Neurosci Res. 2005 May;52(1):47-60. doi: 10.1016/j.neures.2005.01.006. Neurosci Res. 2005. PMID: 15811552
-
Continuous administration of poloxamer 188 reduces overload-induced muscular atrophy in dysferlin-deficient SJL mice.Neurosci Res. 2012 Feb;72(2):181-6. doi: 10.1016/j.neures.2011.10.005. Epub 2011 Oct 21. Neurosci Res. 2012. PMID: 22044584
-
SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression.Stem Cells. 2008 Sep;26(9):2391-8. doi: 10.1634/stemcells.2008-0043. Epub 2008 Jun 26. Stem Cells. 2008. PMID: 18583542
-
Dysferlin function in skeletal muscle: Possible pathological mechanisms and therapeutical targets in dysferlinopathies.Exp Neurol. 2016 Sep;283(Pt A):246-54. doi: 10.1016/j.expneurol.2016.06.026. Epub 2016 Jun 25. Exp Neurol. 2016. PMID: 27349407 Review.
-
Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy.Acta Myol. 2014 Dec;33(3):119-26. Acta Myol. 2014. PMID: 25873780 Free PMC article. Review.
Cited by
-
Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.ILAR J. 2021 Dec 31;62(1-2):77-132. doi: 10.1093/ilar/ilab022. ILAR J. 2021. PMID: 34979559 Free PMC article. Review.
-
Genetic Mapping of Behavioral Traits Using the Collaborative Cross Resource.Int J Mol Sci. 2022 Dec 30;24(1):682. doi: 10.3390/ijms24010682. Int J Mol Sci. 2022. PMID: 36614124 Free PMC article.
-
Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle.Front Physiol. 2014 Feb 19;5:57. doi: 10.3389/fphys.2014.00057. eCollection 2014. Front Physiol. 2014. PMID: 24600403 Free PMC article.
-
Assessment of disease activity in muscular dystrophies by noninvasive imaging.J Clin Invest. 2013 May;123(5):2298-305. doi: 10.1172/JCI68458. Epub 2013 Apr 24. J Clin Invest. 2013. PMID: 23619364 Free PMC article.
-
Distinct effects of contraction-induced injury in vivo on four different murine models of dysferlinopathy.J Biomed Biotechnol. 2012;2012:134031. doi: 10.1155/2012/134031. Epub 2012 Feb 6. J Biomed Biotechnol. 2012. PMID: 22431915 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources